This invention relates to designs that are used to close containers of ophthalmic solutions and methods of using the same.
This application claims priority from a non-provisional filing, U.S. App. Pat. Ser. No. 61/286,937 which was filed on Dec. 16, 2009.
Ophthalmic lenses are extremely popular with consumers, particular the soft contact lenses that are either daily disposable or reusable. There are a variety of solutions that are used provide additional comfort to lens wearers when the lenses are in the eye or when the lenses are removed from the eye for cleaning. Most of these solutions are dispensed to the consumer in multiple use bottles that will be opened and reused over time. Given that these solutions are in contact with the eye, the solutions are sterilized to prevent harmful environmental contaminants such as bacteria, viruses, and the like from infecting the patient. However, with a multiple use bottle, these bottles are opened by the consumer and therefore, the consumer's use of the bottle often introduces such contaminants to the solutions. For example commonly used bottles for contact lens solutions have a short cap which covers the spout from which solutions are dispensed. When consumers open these bottles, their fingers often brush across the spout of the bottle and the material on their hands is a source of contamination for the solutions It would be useful if there was a closure which could be used that inhibits consumers from touching the spouts of bottles when opening or closing said bottles. This need is met by the following invention.
This invention includes a closure for covering a container comprising a base comprising an upper surface and a neck,
The following figures illustrate an embodiment of the invention.
The foregoing closures may be made by a variety of plastic materials such as without limitation, ethylene vinyl alcohol (“EVA”), fluorinated polymers including without limitation, polytetrafluoroethylene (“PTFE”) and polyvinylidene fluoride (“PVDF”), polypropylene, polyethylene, polyisobutylene, nylon, polyurethanes, polyacrylates and methacrylates, polyvinyl palmitate, polyvinyl stearates, polyvinyl myristate, cyanoacrylates, epoxies, silicones, copolymers thereof. The closure is preferably made of polypropylene. Each piece of the closure may be made of a different material or the same material. Any of these pieces may be made of unitary construction with or without the bottle. In the preferred embodiment all pieces of the closure are made of the same material. Any or all of the components of the closure may be made by injection molding (two material injection molding, over-molding, sandwich molding or insert molding). Other combinations of materials and construction methods are known to those of skill in the art of molding plastic materials and although such materials and methods are not specifically mentioned herein they are considered to be included in this invention.
Further the invention includes a closure for covering a container comprising a
Still further, the invention includes a method of storing an ophthalmic lens solution in a bottle comprising a closure which comprises a base comprising an upper surface and a neck,
Yet further still, the invention includes a method of storing an ophthalmic lens solution in bottle comprising a closure which comprises
The aforementioned terms all have their stated meanings and preferred ranges or components. The term “ophthalmic lens solution” means any solution that is used to clean, maintain, or lubricate ophthalmic lenses or the eye of a user of such lenses whether or not such lenses are in the user's eye. Examples of such solutions include any composition which can be directly instilled into an eye, or which can be used to soak, clean, rinse, store or treat any ophthalmic device which can be used placed in or on the eye. Examples of ophthalmic compositions that may be topically administered to the eye, ophthalmic device packing solutions, cleaning solutions, conditioning solutions, storage solutions, eye drops, eye washes, as well as ophthalmic suspensions, aerosols, gels and ointments and the like. In one embodiment of the present invention, the ophthalmic composition is a multipurpose lens care solution. The multipurpose lens care solution may contain a disinfectant. The disinfecting agent should not cause stinging or damage to the eye at use concentrations and should be inert with respect to the other composition components. Suitable disinfecting components include hydrogen peroxide, polymeric biguanides, polymeric quarternary ammonium compounds, chlorites, bisbiguanides, quarternary ammonium compounds and mixtures thereof. The multipurpose lens care solution may also contain one or more lubricating agents may also be included in the ophthalmic composition. Lubricating agents include water soluble cellulosic compounds, hyaluronic acid, and hyaluronic acid derivatives, chitosan, water soluble organic polymers, including water soluble polyurethanes, polyethylene glycols, combinations thereof and the like. Specific examples of suitable lubricating agents include polyvinyl pyrrolidone (“PVP”), hydroxypropyl methyl cellulose, carboxymethyl cellulose, glycerol, propylene glycol, 1,3-propanediol, polyethylene glycols, mixtures there of and the like. The multipurpose lens care solution may also contain one or more surfactant, detergent, or mixtures thereof. Suitable examples include tyloxapol, poloxomer (poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide)) type surfactants which are commercially available from BASF and poloxamine type surfactants (non-ionic, tetrafunctional block copolymers based on ethylene oxide/propylene oxide, terminating in primary hydroxyl groups, commercially available from BASF, under the tradename Tetronic). A specific example is Pluronic F-147 and Tetronic 1304. Tyloxapol is a non-ionic, low molecular weight surfactant, and is fully soluble in the phosphate buffers. Tyloxapol is a detergent commercially available from Pressure Chemical Company. The multipurpose lens care solution may also contain one or more viscosity adjusting agent or thickener. Suitable viscosity adjusting agents are known in the art and include polyvinyl alcohol, polyethylene glycols, guar gum, combinations thereof and the like. The viscosity adjusting agent may be used in amounts necessary to achieve the desired viscosity. The multipurpose lens care solution may further comprise additional components such as, but not limited to pH adjusting agents, tonicity adjusting agents, buffering agents, active agents, lubricating agents, disinfecting agents, viscosity adjusting agents, surfactants and mixtures thereof. When the ophthalmic composition is an ophthalmic solution, all components in the ophthalmic solution of the present invention should be water soluble. As used herein, water soluble means that the components, either alone or in combination with other components, do not form precipitates or gel particles visible to the human eye at the concentrations selected and across the temperatures and pH regimes common for manufacturing, sterilizing and storing the ophthalmic composition.
The multipurpose lens care solution may also contain one or more active agent. A wide variety of therapeutic agents may be used, so long as the selected active agent is inert in the presence of peroxides. Suitable therapeutic agents include those that treat or target any part of the ocular environment, including the anterior and posterior sections of the eye and include pharmaceutical agents, vitamins, nutraceuticals combinations thereof and the like. Suitable classes of active agents include antihistamines, antibiotics, glaucoma medication, carbonic anhydrase inhibitors, anti-viral agents, anti-inflammatory agents, non-steroid anti-inflammatory drugs, antifungal drugs, anesthetic agents, miotics, mydriatics, immunosuppressive agents, antiparasitic drugs, anti-protozoal drugs, combinations thereof and the like. When active agents are included, they are included in an amount sufficient to produce the desired therapeutic result (a “therapeutically effective amount”).
The advantages of the invention are many. For example, users of containers of ophthalmic lens solutions which are closed with the closures of the invention are substantially inhibited from touching the spout of such closures upon opening such containers. This reduces the chance that the consumer will contaminate an ophthalmic solution stored in such containers.
To determine whether bottles closed with the closures of the invention inhibited a user from touching the spout when opening a bottle of contact lens solution, the following test was conducted. The bottles topped with the closures of the invention,
The foregoing embodiments are only meant to illustrate the invention and not limit it. Those knowledgeable in closures as well as other specialties may find other methods of practicing the invention. However, those methods are deemed to be within the scope of this invention.
Number | Date | Country | |
---|---|---|---|
61286937 | Dec 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12967822 | Dec 2010 | US |
Child | 13804736 | US |